Log in or Sign up for Free to view tailored content for your specialty!
Diabetes News
Hybrid Heart in Diabetes conference offers ‘new twist’ on latest cardiometabolic research
Experts across the cardiorenal metabolic specialties will again convene to present innovative research on the relationship between type 2 diabetes, CVD and renal disease, including controversial debates and panel discussions.
Diabetes screening based on race, ethnicity may lead to more equitable care
Black, Hispanic and Asian Americans may be at risk for developing diabetes at lower weights and younger ages than white Americans, according to a study in Annals of Internal Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
Screening updates for prediabetes, diabetes may increase detection
Implementing new guidelines would increase screening eligibility and detection of diabetes and prediabetes, according to an analysis published in JAMA.
COVID-19 leading cause of death in people with diabetes in fourth quarter of 2020
The proportion of deaths attributed to COVID-19 in people with diabetes in the U.S. in the last 3 months of 2020 was slightly higher than the percentage of people who died due to cardiovascular disease or diabetes, according to study data.
Speaker discusses Kidney Disease: Improving Global Outcomes guideline updates
BOSTON — In a review of the Kidney Disease: Improving Global Outcomes recommendations, a speaker discussed the Kidney Disease Outcomes Quality Initiative commentary on the updated guidelines here.
Sotagliflozin improves outcomes in adults with and without prior CVD
WASHINGTON — The dual SGLT inhibitor sotagliflozin reduced total CV death, MI and stroke in adults with type 2 diabetes and chronic kidney disease both with and without prior CVD, according to new analyses of the SCORED trial.
Diabetes complications less likely in non-vitamin K antagonist oral anticoagulant users
Adults with atrial fibrillation and diabetes who received non-vitamin K antagonist oral anticoagulants had a lower risk for diabetes complications and mortality than those who received warfarin, a retrospective cohort study showed.
Adding empagliflozin to standard of care may be cost-effective for diabetic kidney disease
For commercial insurers and Medicare, it may be cost-effective to add empagliflozin to the standard of care treatment for patients with diabetic kidney disease, according to data published in the American Journal of Kidney Diseases.
Geographic disparities in CKD rate found among patients with, without type 2 diabetes
Between 2013 and 2018, geographic disparities in the prevalence of chronic kidney disease increased in the Southeastern region of the U.S., according to data published in Kidney Medicine.
Women with diabetes less likely to get mammograms
Women with diabetes were significantly less likely to complete a mammogram than women without the condition, according to an analysis of electronic health records from a single institution.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read